Drug Type Antibody fusion proteins |
Synonyms IL-12-Anti-Target A |
Target |
Action antagonists, modulators |
Mechanism FAP antagonists(Fibroblast activation protein alpha antagonists), IL-12R modulators(Interleukin-12 receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | South Korea | 30 Apr 2025 |